Summary : From 1978 through 1987, 321 patients who had functional tricuspid regurgitation (TR) associated with mitral or combined mitral and aortic valve disease underwent tricuspid annuloplasty with our modification of the original De Vega's annuloplasty technique.
The modified e Vega's annuloplasty consisted of two separate semicircular sutures placed around the anterior and lateral aspect of the tricuspid valve. Preoperatively, 229 (71.3%) of the 321 patients were inNew York Heart Association functional class IQ or IV. There were nineteen early deaths (5.9%), and15 patients died during a follow-up period of 15 to 126 months (mean follow-up, 26 months).
Five patients (1.5%) required reoperation because of biological mitral valve failure and recurrence ofmitral stenosis. The severity of TR was evaluated by twodimensional and pulsed Doppler echocardiography, and was classified on a scale of 0 to Grade 3 according to the maximal distance and the flow pattern of the regurgitant signals in the right atrium. Postoperative echocardiographic evaluation of TR was performed in 121 randomly selected patients late after operation.
TR reduced to Grade 1 or less in 107 (88.4%) of the 121 patients after operation.
Ninety-six percent of the survivors were in New York Heart Association functional class I or II, postoperatively. The actuarial survival rate for the 321 patients with the modified De Vega's annuloplasty including early deaths was 88.2% at 10 years and the actuarial rate of freedom from reoperation on the tricuspid valve was 97.6%. Our surgical experience indicated that the modifiedDe Vega's annuloplasty, as the method of first choice, is a simple, reliable procedure and resulted in reduction of the severity of TR in 88.4% of the patients with functional TR.
Introduction
Tricuspid regurgitation (TR) may be present in 10% to 50% of patients with advanced mitral or combined mitral and aortic valve disease (Simon et al. 1980; Cohen et al. 1987; Goldman et al. 1987; Czer et al. 1989 were detected in the right atrium during the whole systolic phase; Grade 3 (severe TR)-for regurgitant signals longer than 2 cm that showed a narrow-band velocity spectrum (the flow pattern was laminar).
Operative procedure All patients were operated on with cardiopulmonary bypass through a median sternotomy.
Before cannulation of the venae cavae, a digital exploration of the tricuspid valve was made to confirm the severity of TR and the location of the regurgitant jet in the tricuspid orifice. The heart was arrested with cold crystalloid cardioplegia.
After the mitral or the combined mitral and aortic valve repairs were performed, the tricuspid valve was examined.
If there was a regurgitantsignal of 20 mm or more as estimated by pulsed Doppler echocardiography preoperatively, or if the dilated annulus was more than 35 mm in diameter intraoperatively, annuloplasty was indicated. One 2-0 Nespolene suture with a Teflon felt pledget which was placed around the anterior aspect ofthe valve was started at about 5 mm beyond the anteroseptal commissure over the septal annulus. The other suture with a Teflon felt pledget was placed around the lateral aspect, and was started at about 5 mm beyond the posteroseptal commissure over the septal annulus.
Both sutures ended at the middle of the annulus between the two commissures, and were tied down on another Teflon feltpledget.
The diameter of the annulus was reduced to 30 mm with an obtulator.
After completion of the annuloplasty, the saline solution injection test was done to confirm valve competence.
Results
Early deaths Nineteen (5.9 %) of the 321 patients died within 30 days after operation.
The causes of early death were low cardiac output syndrome in 13, multi-organ failure in 2, and acute renal failure in 2 patients, and cardiac tamponade and pneumonia in 1 patient each. There were no deaths related to the modified De Vega's annuloplasty itself. rence of mitral stenosis, 3 patients; failure of the biological mitral valve, 2 patients), and asecond tricuspid annuloplasty was performed 6 to 156 months (mean of 109 months) after the initial operation.
Reoperation -free rate after the modified De Vega's annuloplasty was 97. 6% at 10 years postoperatively.
Echocard iographic Evaluation
In 121 randomly selected patients, the severity of TR was evaluated by twodimensional and pulsedDoppler echocardiography before and after operation (Fig.  2) 
Discussion
Tricuspid regurgitation may be present in 10% to 50% of patients with a severe mitral valve disease or combined mitral and aortic valve disease (Simon et al. 1980; Cohen et al. 1987b; Goldman et al. 1987; Czer et al. 1989 ). Yet, the surgical management of acquired TR remains controversial.
There is a general consensus that an organically diseased or deformed valve should be replaced, however, for surgical management of functional TR, opinions vary as to whether to expect spontaneous regression of the TR after repair of left-sided valve lesions or to perform tricuspid annuloplasty or even valve replacement.
This controversy may be partly due to lack of precise diagnostic method for TR (Cohen et al. 1987 a; Goldman et al. 1987; Czer et al. 1989 At operation, the decision of whether to repair or replace is crucial. Tricuspid annuloplasty is attractive because it is a simple and short procedure.
Three annuloplasty repairs have been applied to functional TR. Bicuspidarization annuloplasty, described by Kay et al. (1965 ), Boyd et al. (1974 is a simple technique, and has a satisfactory late result (Nakano et al. 1988) . Semicircular suture annuloplasty (De Vega et al. 1972 ) and annuloplasty with a flexible prosthetic ring (Duran and Ubago, 1976) et al. 1974; Grondin et al. 1975; Duran et al. 1980; Simon et al. 1980 ). In our series, 9 of the 14 patients in whom the severity of TR was evaluated as Grade 2 to 3 postoperatively, demonstrated deterioration or persistence of left-sided valve lesions, and 5 of the 9 patients required reoperation on the tricuspid valve. Pluth and Ellis (1969) and Breyer et al. (1976) reported that valve replacement was appropriate in patients with moderate to severe TR because of the unsatisfactory results of tricuspid annuloplasty. Although tricuspid valve replacement results in complete repair of the tricuspid valve in patients with severe congestive heart failure and in predictable early results, a high incidence of valve thrombosis and a high early mortality in tricuspid valve replacement were reported (Thorburn et al. 1983) . It was also documented that long-term survival rate in patients with tricuspid valve replacement was lower than in those with tricuspid annuloplasty (Kratz et al. 1985) . Therefore, Kratz et al. (1985) concluded that tricuspid valve replacement should be avoided except when the tricuspid valve is destroyed or cannot be repaired. 
